Skip to NavigationSkip to content

New chief executive for Medivir

Published on: 14/08/14

Niklas Prager has been named as the new president and chief executive of Sweden-based pharma firm Medivir.

Starting in September, Prager has been on Medivir’s board since May and is to replace Maris Hartmanis who is leaving the company.

Prager’s previous roles include working for Merck both in the US and Sweden, and serving as the chief executive in Sweden for Pfizer, Envirotainer and Qbtech.

“I am delighted to welcome Niklas to the position of chief executive of Medivir,” says Birgitta Stymne Göransson, chairman of the board of directors of Medivir. “Niklas has a background in both biotech and big pharma, and his large network of contacts in the Swedish and international pharmaceutical industries make him an ideal choice for us.”

Prager adds: “Together with the board, the highly skilled research team and all other Medivir employees, I will be focussing on further value creation and enhanced visibility of Medivir’s potential.”

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches